Chunchun Qi
Changhongjie, 300071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery of Potential Scaffolds for Methionine Adenosyltransferase 2A (MAT2A) Inhibitors: Virtual Screening, Synthesis, and Biological Evaluation.
Journal: Molecules (Basel, Switzerland)
Published: March 31, 2025
Adipocyte-specific Zeb1 downregulation remodels the tumor-associated adipose microenvironment to facilitate female breast cancer progression.
Journal: Nature communications
Published: August 29, 2024
Trimethyl chitosan-cysteine-based nanoparticles as an effective delivery system for portulacerebroside A in the management of hepatocellular carcinoma cells in vitro and in vivo.
Journal: Journal of drug targeting
Published: April 16, 2024
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells.
Journal: Acta pharmaceutica Sinica. B
Published: March 13, 2024
Nanofiber-based delivery of evodiamine impedes malignant properties of intrahepatic cholangiocarcinoma cells by targeting HDAC4 and restoring TPM1 transcription.
Journal: Human cell
Published: November 22, 2023
Bacterial metabolism-triggered-chemiluminescence-based point-of-care testing platform for sensitive detection and photothermal inactivation of Staphylococcus aureus.
Journal: Analytica chimica acta
Published: August 11, 2023
SP1 transcriptionally regulates UBE2N expression to promote lung adenocarcinoma progression.
Journal: Molecular biomedicine
Published: December 12, 2022
USP51/PD-L1/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer.
Journal: Cancer communications (London, England)
Published: November 11, 2022
Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1.
Journal: Discover oncology
Published: October 04, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026